Koers SINTX Technologies Inc Nasdaq
Aandelen
US8293921099
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 3,3 mln. 3,07 mln. | Omzet 2025 * | 3,91 mln. 3,63 mln. | Marktkapitalisatie | 4,89 mln. 4,55 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -14 mln. -13 mln. | Nettowinst (verlies) 2025 * | -14 mln. -13 mln. | EV/omzet 2024 * | 1,48 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,25 x |
K/w-verhouding 2024 * |
-0,44
x | K/w-verhouding 2025 * |
-0,73
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
B. Bal
CEO | Chief Executive Officer | 61 | 08-02-12 |
Ryan Bock
CTO | Chief Tech/Sci/R&D Officer | - | - |
David O’Brien
COO | Chief Operating Officer | 59 | 01-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Stookey
BRD | Director/Board Member | 53 | 06-10-14 |
Jeffrey White
BRD | Director/Board Member | 70 | 28-01-14 |
David Truetzel
BRD | Director/Board Member | 67 | 01-09-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,39% | 126 mld. | |
-6,86% | 10,96 mld. | |
+2,52% | 8,97 mld. | |
+38,96% | 5,56 mld. | |
-17,50% | 4,99 mld. | |
+8,36% | 3,44 mld. | |
-8,84% | 2,8 mld. | |
-7,52% | 2,18 mld. | |
-3,00% | 2,16 mld. |